Bedaquiline can act as core drug in a standardized treatment regimen for fluoroquinolone-resistant rifampicin-resistant tuberculosis

Tom Decroo; Kya Jai; Maug Aung; Mohamed Anwar Hossain; Mourad Gumusboga; Nimer Ortuno-Gutierrez; Bouke Catherine de Jong; Armand Van Deun

doi:10.1183/13993003.02124-2021

Bedaquiline can act as core drug in a standardized treatment regimen for fluoroquinolone-resistant rifampicin-resistant tuberculosis

Tom Decroo, Kya Jai, Maug Aung, Mohamed Anwar Hossain, Mourad Gumusboga, Nimer Ortuno-Gutierrez, Bouke Catherine de Jong, Armand Van Deun

Research output: Contribution to journal › Letter › peer-review

47 Downloads (Pure)

Original language	English
Article number	2102124
Journal	European Respiratory Journal
Volume	59
Issue number	3
ISSN	0903-1936
DOIs	https://doi.org/10.1183/13993003.02124-2021
Publication status	Published - 2022

Access to Document

10.1183/13993003.02124-2021Licence: CC BY-NC

2021erjo2102124Final published version, 322 KBLicence: CC BY-NC

Cite this

@article{878e485cf1664062a316225d21d23284,

title = "Bedaquiline can act as core drug in a standardized treatment regimen for fluoroquinolone-resistant rifampicin-resistant tuberculosis",

author = "Tom Decroo and Kya Jai and Maug Aung and Hossain, {Mohamed Anwar} and Mourad Gumusboga and Nimer Ortuno-Gutierrez and {de Jong}, {Bouke Catherine} and {Van Deun}, Armand",

note = "FTX; (CC BY-NC 4.0)",

year = "2022",

doi = "10.1183/13993003.02124-2021",

language = "English",

volume = "59",

journal = "European Respiratory Journal",

issn = "0903-1936",

publisher = "European Respiratory Society Journals",

number = "3",

}

TY - JOUR

T1 - Bedaquiline can act as core drug in a standardized treatment regimen for fluoroquinolone-resistant rifampicin-resistant tuberculosis

AU - Decroo, Tom

AU - Jai, Kya

AU - Aung, Maug

AU - Hossain, Mohamed Anwar

AU - Gumusboga, Mourad

AU - Ortuno-Gutierrez, Nimer

AU - de Jong, Bouke Catherine

AU - Van Deun, Armand

N1 - FTX; (CC BY-NC 4.0)

PY - 2022

Y1 - 2022

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000792497500028

U2 - 10.1183/13993003.02124-2021

DO - 10.1183/13993003.02124-2021

M3 - Letter

C2 - 34561288

SN - 0903-1936

VL - 59

JO - European Respiratory Journal

JF - European Respiratory Journal

IS - 3

M1 - 2102124

ER -

Bedaquiline can act as core drug in a standardized treatment regimen for fluoroquinolone-resistant rifampicin-resistant tuberculosis

Access to Document

Other files and links

Cite this